NEPHROS INC (NEPH) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $5.40M | +43.6% |
| 2024 | $3.76M | -12.7% |
| 2023 | $4.31M | +18.5% |
| 2022 | $3.63M | -47.9% |
| 2021 | $6.97M | -15.5% |
| 2020 | $8.25M | +98.0% |
| 2019 | $4.17M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $5.40M | +43.6% |
| 2024 | $3.76M | -12.7% |
| 2023 | $4.31M | +18.5% |
| 2022 | $3.63M | -47.9% |
| 2021 | $6.97M | -15.5% |
| 2020 | $8.25M | +98.0% |
| 2019 | $4.17M | — |